Biểu đồ giá cổ phiếu RDGL
RDGL Thu nhập
Vivos Inc
$0.06
2.3%
$0
Khi đóng cửa: May 15, 16:00:00 GMT-4
$0.06
-2.65%
$0
Phiên sau giờ: May 15, 20:00:00 GMT-4
Quay lại
Vivos Inc (RDGL) Thu nhập
Thống kê chính
Giá đóng cửa trước
$0.0662
Giá mở cửa
$0.066
Phạm vi ngày
$0.066 - $0.0687
Phạm vi 52 tuần
$0.0425 - $0.1547
Khối lượng
118.5K
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
--
EPS (TTM)
-0.01
Vốn hóa thị trường
$31.8M
RDGL là gì?
Vivos, Inc. is a radiation oncology medical device company. The company is headquartered in Richland, Washington. The company went IPO on 2001-08-08. The firm has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.
